Currently marketed for research use by Biofluidica, the test's microfluidic channels use specific cancer antibodies to detect
capture circulating tumor cells.
The scientists used a highly innovative cell separation technology Parsortix ™, developed by UK company ANGLE plc that is able to
capture the circulating tumor cells.
«Our chip is currently the only device that can potentially
capture circulating tumor cells and exosomes directly on the chip, which should increase its ability to detect metastasis.
Not exact matches
Now a team of researchers in China has developed a new microfluidic chip that can quickly and efficiently segregate and
capture live
circulating tumor cells (CTCs) from a patient's blood, with potential applications for cancer screenings and treatment assessments.
«Our
circulating tumor cell device can release a
tumor cell captured from a blood sample, enabling single
cell analysis,» says Liu.
The results were published in the journal Lab on a Chip (Lab on a Chip 17 (19), 3291 - 3299) in an article called: «Magnetic particles assisted
capture and release of rare
circulating tumor cells using wavy - herringbone structured microfluidic devices.»
Liu's «lab on a chip» is notable for its ability to not only
capture tumor cells circulating in the blood, but to «release» those
cells as well.
We have invented new biomaterial surfaces based on natural halloysite nanotubes, that
capture rare
circulating tumor cells (CTCs) from blood while simultaneously repelling white blood
cells.
The herringbone pattern of interior surfaces in the HB - Chip brings more
circulating tumor cells into contact with the antibody - coated
capture surfaces.